Predictors of Weight Loss in Children With Attention Deficit Hyperactivity Disorder Treated With Stimulant Medication
The DOI matches its Crossref record.
Abstract
Objective. A retrospective study was undertaken to examine predictors of weight loss in children with attention deficit hyperactivity disorder (ADHD) treated with stimulant medication. Design. Children diagnosed with ADHD and treated with methylphenidate hydrochloride (MPH) or dextroamphetamine sulfate (DEX) for at least 5 months were identified by retrospective chart review. Analyses were performed on 32 children (29 boys) treated with MPH and 28 children (25 boys) treated with DEX. Variables examined included pretreatment weight, pretreatment body mass index (BMI), duration of treatment, total daily dose, and weight-adjusted dose. Results. The MPH-treated group was initially seen at a mean age (± standard deviation) of 7.5 years (±2.1). Mean duration of follow-up was 11.2 months (±3.8). Mean total daily dose was 25.5 mg (±8.2) and mean weight-adjusted dose was 1.0 mg/kg/day (±.5). Mean change in weight as expressed in z scores was -0.4 SD (±.7). The DEX-treated group was initially seen at a mean age of 9.3 years (±2.7). Mean duration of follow-up was 10.8 months (±4.1). Mean total daily dose was 14.9 mg (±8.2) and mean weight-adjusted dose was .5 mg/kg/day (±.3). Mean change in weight was -0.6 SD (±.6). Although the MPH group was younger than the DEX group, there were no between-group differences in weight or height either before treatment or at follow-up when adjusted for age and gender. Using linear regression analysis, significant correlations were found between pretreatment weight and change in weight for both the MPH-treated group (r = .63) and the DEX-treated group (r = .47). Stepwise multiple-regression analysis indicated that pretreatment age, weight-adjusted dose, and duration of follow-up did not significantly contribute to the variance in change of weight for either the MPH- or DEX-treated groups. To adjust for height, changes in BMI were also analyzed. For both medication groups, no differences were found between the heavier (BMI≥50%) and thinner (BMI <50%) children in duration of follow up, total daily dose, or weight-adjusted dose. When the medication groups were combined, a greater proportion of heavier children experienced a decrease relative to their predicted BMI compared with thinner children (80% vs 52%). Comparisons of mean BMI slopes revealed that the heavier group experienced an absolute decrease in their BMI (-.139) in contrast to the thinner group (+.014) (t = 2.70). Conclusions. Pretreatment weight, adjusted for age, gender, and height, is a significant predictor of weight loss in children with ADHD treated with either MPH or DEX. In contrast, pretreatment age, duration of treatment, and weight-adjusted dose were not found to be significant predictors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement (2001) · Pediatrics · doi:10.1542/peds.108.4.1033 · Cited by 878
Food reinforcement and eating: A multilevel analysis.
Epstein, L. H., Leddy, J. J., Temple, J. L., & Faith, M. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.5.884 · Cited by 381
Nederkoorn, C., Smulders, F. T. Y., Havermans, R. C., Roefs, A., & Jansen, A. (2006) · Appetite · doi:10.1016/j.appet.2006.05.008 · Cited by 374
Storebø, O. J., Pedersen, N., Ramstad, E., Kielsholm, M. L., Nielsen, S. S., Krogh, H. B., Moreira-Maia, C. R., Magnusson, F. L., Holmskov, M., Gerner, T., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012069.pub2 · Cited by 321
Waring, M. E., & Lapane, K. L. (2008) · Pediatrics · doi:10.1542/peds.2007-1955 · Cited by 294
Metadata
- Authors
- Schertz, M., Adesman, A. R., Alfieri, N. E., & Bienkowski, R. S.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1996-10-01
- Volume
- 98
- Issue
- 4
- Pages
- 763-769
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2122412443
- Cited by
- 70
- References
- 0
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of Weight Loss in Children With Attention Deficit Hyperactivity Disorder Treated With Stimulant Medication. https://app.cochat.ai/papers/10.1542/peds.98.4.763
- The paper
- Schertz, M., Adesman, A. R., Alfieri, N. E., & Bienkowski, R. S. (1996). Predictors of Weight Loss in Children With Attention Deficit Hyperactivity Disorder Treated With Stimulant Medication. Pediatrics. https://doi.org/10.1542/peds.98.4.763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.